News

An advocate for New Brunswick patients suffering from unusual neurological symptoms is calling for the retraction of a recent scientific report that found no evidence of a mystery brain disease in the ...
However, in both cases, NICE immediately published draft guidance that concluded the anti-amyloid drugs were too expensive to ...
Genetic disease impacts millions of children in the U.S., with Down syndrome, cystic fibrosis, Tay-Sachs disease and sickle cell disease among the most common.
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Some of the emerging tech is already making a difference in patient care and is changing how doctors treat cancer, strokes ...
The Long Island Museum, 1200 Route 25A, Stony Brook will host the 9th Annual Arts & Alzheimer’s Conference on Thursday, June ...
Explore key strategies for managing dementia confusion and Alzheimer’s. Learn about recognizing signs, using the Confusion Assessment Method, and adapting daily routines for better care of affected in ...
EndAlz Festival brought together caregivers, advocates and those affected by Alzheimer's disease for a casino-style fundraising event ...
A Madison-based startup is working on a new approach to drug development that could reduce or replace the need for animal ...
Nearly 7,000 Floridians are living with Alzheimer’s disease, making it the second-highest in the nation. Wisdom Adult Day ...
A U.K. health agency said the Alzheimer's drugs Kisunla and Leqembi are not cost-effective, meaning they won't be offered through the NHS.
Galpin said his mother’s general demeanor improved, and as a former cheerleader, she gets particularly excited when local cheerleaders stop by.